Metastatic breast cancer survivor Reverend Tawana Davis, PhD, shares what it was like being diagnosed with advanced cancer, how she coped with treatment side effects, and how she is choosing to live with gratitude.
Read research from the December 2022 session of the ASCO Plenary Series, which explores combining immunotherapy for advanced non-small cell lung cancer with high PD-L1.
In this podcast, Dr. Manali Patel interviews Stephanie Walker about her experience living with metastatic breast cancer, how she got involved with patient advocacy, and her work leading the BECOME Research project to increase Black patient participation in clinical trials.
Read research from the 2022 ASCO Quality Care Symposium, including studies on how cancer navigation programs and lower-cost drug alternatives can lower the cost of care and a study on how Medicaid expansion affected the rates of metastatic cancer diagnoses and cancer deaths.
In this post, Dr. Cristina Rodriguez and Dr. Natalie Uy describe what to know about caring for a loved one with advanced head and neck cancer toward the end of life, including the challenges unique to people with this type of cancer and how to get help.
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2022 ASCO Annual Meeting in head and neck cancer, brain tumors, and health equity.
In this podcast, members of the American Society of Clinical Oncology (ASCO) discuss new research presented at the 2022 ASCO Annual Meeting in multiple myeloma, breast cancer, and cancer in people age 60 or older.
Dr. H. Jack West shares what people with lung cancer should know about biomarker testing, including why it is important in planning treatment and what to expect during the testing process.
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include advances in treating HER2-low metastatic breast cancer, RAS wild-type metastatic colorectal cancer, recurrent and refractory Ewing sarcoma, and newly diagnosed multiple myeloma.
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include targeted therapy for advanced hormone receptor-positive, HER2-negative breast cancer and using liquid biopsy to guide post-surgery treatment decisions for stage II colon cancer.
